Skip to content
Recall Observatory FDA recall evidence

Drug product

Cinacalcet Tablets, 90 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-833-30), b) 500-count HDPE bottle (NDC 65862-833-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India. 90 mg - 30 Tablets - NDC 65862-833-30 90 mg - 500 Tablets - NDC 65862-833-05

D-0079-2025

November 07, 2024

Class II

Product summary

Firm
Aurobindo Pharma USA Inc
Event
Event 95730
Status
Ongoing
Classification
Class II
Quantity
Unavailable
Official record key
drug-enforcement:D-0079-2025

Official wording

Reason: cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

Code information: Lot #: a) CFSC23001A, CFSC23001B, Exp 03/31/2025; b) P2300195, Exp 12/31/2024

Distribution pattern: USA Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-nitroso Cinacalcet impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations